Pricing Log in Create free account

MannKind Corporation (MNKD) vs Silence Therapeutics PLC Sponsored ADR (SLN)

MannKind Corporation and Silence Therapeutics PLC Sponsored ADR are both Biotechnology companies. MannKind Corporation and Silence Therapeutics PLC Sponsored ADR are of similar size ($1.2B and $1.2B). MannKind Corporation grew revenue faster over the last twelve months: 31.7% against −97.0%. Silence Therapeutics PLC Sponsored ADR has the higher net margin (0.00% vs −18.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, MannKind Corporation leads on 8 and Silence Therapeutics PLC Sponsored ADR on 7.

Valuation

Metric MNKD SLN Biotechnology median
P/E n/m n/m 10.60
P/S 3.04 1,110.83 9.40
P/B n/m 24.23 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 50.23 n/m 0.66
EV/Sales 3.82 1,025.03 9.02
Earnings yield (5.87%) (6.49%) (32.88%)
Free cash flow yield (6.25%) (4.54%) (23.13%)

Profitability

Metric MNKD SLN Biotechnology median
Gross margin 0.00% 79.50% 68.51%
Operating margin (2.88%) 0.00% 0.00%
Net margin (18.10%) 0.00% 0.00%
Free cash flow margin (18.97%) 0.00% 0.00%
Return on equity 182.90% (90.41%) (51.96%)
Return on assets (12.29%) (44.14%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MNKD SLN Biotechnology median
Revenue growth (TTM) 31.74% (96.97%) 6.76%
EPS growth (last fiscal year) (80.00%) (90.91%) 29.88%
Revenue growth, 5-year CAGR 39.89% (39.74%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MNKD SLN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.22 7.42 4.97
Net debt to EBITDA 5.32 0.94 1.01

Dividend

Metric MNKD SLN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MNKD SLN Biotechnology median
Market cap 1.21b 1.23b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack